➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
McKinsey
Dow
McKesson
AstraZeneca

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

PIOGLITAZONE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Pioglitazone Hydrochloride patents expire, and when can generic versions of Pioglitazone Hydrochloride launch?

Pioglitazone Hydrochloride is a drug marketed by Accord Hlthcare, Annora Pharma, Aurobindo Pharma Ltd, Celltrion, Macleods Pharms Ltd, Mylan Pharms Inc, Nostrum Labs Inc, Prinston Inc, Puracap Pharm Llc, Sandoz, Shuangcheng, Teva Pharms Usa, Torrent Pharms Ltd, Us Antibiotics, Zydus Pharms Usa Inc, and Mylan. and is included in twenty-two NDAs.

The generic ingredient in PIOGLITAZONE HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.

Drug patent expirations by year for PIOGLITAZONE HYDROCHLORIDE
Recent Clinical Trials for PIOGLITAZONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Humanitas Hospital, ItalyPhase 2
Mario Negri Institute for Pharmacological ResearchPhase 2
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2

See all PIOGLITAZONE HYDROCHLORIDE clinical trials

Paragraph IV (Patent) Challenges for PIOGLITAZONE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
ACTOS TABLET;ORAL pioglitazone hydrochloride 021073

US Patents and Regulatory Information for PIOGLITAZONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Antibiotics PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078383-002 Mar 12, 2013 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Shuangcheng PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 210165-002 Jan 22, 2021 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Aurobindo Pharma Ltd PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE metformin hydrochloride; pioglitazone hydrochloride TABLET;ORAL 200823-002 Feb 13, 2013 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 202456-003 Feb 13, 2013 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
McKinsey
Dow
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.